| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Pathology, Anatomy, and Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania 19107 [P. P. C., C. M. H., C. P., G. R, C. M., A. G.]; Sbarro Institute for Cancer Research and Molecular Medicine, Philadelphia, Pennsylvania 19107 [P. P. C., C. M. H., C. P., A. G.]; Dipartimento di Scienze Odontostomatologiche e Maxillo-Facciali, University of Naples "Federico II," 80100 Napoli, Italy [P. P. C.]; Istituto di Citomorfologia Normale e Patologica, Consiglio Nazionale delle Ricerche, c/o Istituti Ortopedici Rizzoli, 40136 Bologna, Italy [C. C., N. M. M.]; Laboratorio di Biologia Cellulare e Microscopia elettronica, Istituti di Ricerca "Codivilla Putti," IOR, 40100 Bologna, Italy [N. M. M.]; Hamon Center for Ther. Onc. Res., University of Texas Southwestern Medical Center, Dallas, Texas 75235-8593 [J. D. M.]; Bristol-Meyers Squibb, Princeton, New Jersey 08543-4000 [L. G.]; Institute di Anatomia e Istologia Patologica, Universita di Siena, 53100 Siena, Italy [L. L.]; Dipartimento di Scienze Oftalmologiche e Neurochirurgiche, Universita di Siena, 53100 Siena, Italy [G. M. T.]; Azienda Ospedaliera Cotugno, Servizio di Anatomia, Istologia e Citologia Patologica, Napoli, Italy [P. M.]; Istituto di Malattie dellApparato Respiratorio, II Universita degli Studi di Napoli, Istituto di Ricerca Cardio-Pneumologico A. O. "Monaldi," Napoli, Italy [M. C.]; and Istituto di Anatomia Patologica, Facolta di Medicina, II Universita di Napoli, Napoli 80122, Italy [G. G. G.]
The retinoblastoma (Rb) family consists of the tumor suppressor pRb/p105 and related proteins p107 and pRb2/p130. Recent immunohistochemical studies of the retinoblastoma family of proteins in 235 specimens of lung cancer show the tightest inverse association between the histological grading in the most aggressive tumor types and pRb2/p130. This led us to study a panel of human lung cancers for mutations in the RB2/p130 gene. Mutations in the Rb-related gene RB2/p130 were detected in 11 of 14 (78.5%) primary lung tumors by single-strand conformation polymorphism and sequence analysis. A Moloney leukemia virus-based retroviral system was set up, and a comparable viral concentration of 1 x 107 infectious units/ml was obtained. Retrovirus-mediated delivery of wild-type RB2/p130 to the lung tumor cell line H23 potently inhibited tumorigenesis in vitro and in vivo, as shown by the dramatic growth arrest observed in a colony assay and the suppression of anchorage-independent growth potential and tumor formation in nude mice. The tumors transduced with the RB2/p130 retrovirus diminished in size after a single injection, and a 12-fold reduction in tumor growth after RB2/p130 transduction compared with the Pac-transduced tumors (92% reduction, P = 0.003) and lacZ-transduced tumors (93% reduction, P < 0.001) was found to be statistically significant. These findings provide the missing confirmation that RB2/p130 is a "bona fide" tumor suppressor gene and strengthen the hypothesis that it may be a candidate for cancer gene therapy for lung cancer.
This article has been cited by other articles:
![]() |
V. Masciullo, E. Berardengo, A. Boglione, A. Sgambato, A. Bernardi, M. Forni, A. Linari, L. Cito, G. Scambia, A. Comandone, et al. The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas Clin. Cancer Res., August 1, 2008; 14(15): 4775 - 4779. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Russo, A. Zamparelli, C. M. Howard, C. Minimo, C. Bellan, G. Carillo, L. Califano, L. Leoncini, A. Giordano, and P. P. Claudio Expression of Cell Cycle-Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic Implications Clin. Cancer Res., May 1, 2005; 11(9): 3265 - 3273. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meuwissen and A. Berns Mouse models for human lung cancer Genes & Dev., March 15, 2005; 19(6): 643 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma Carcinogenesis, August 1, 2004; 25(8): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Andrilli, V. Masciullo, L. Bagella, T. Tonini, C. Minimo, G. F. Zannoni, R. L. Giuntoli II, J. A. Carlson Jr., D. R. Soprano, K. J. Soprano, et al. Frequent Loss of pRb2/p130 in Human Ovarian Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3098 - 3103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marino, D. Hoogervoorst, S. Brandner, and A. Berns Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence Development, August 1, 2003; 130(15): 3359 - 3368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputi, A. M. Groeger, V. Esposito, A. De Luca, V. Masciullo, A. Mancini, F. Baldi, E. Wolner, and A. Giordano Loss of pRb2/p130 Expression Is Associated with Unfavorable Clinical Outcome in Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3850 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Alvi, R Hogg, J S Rader, M J Kuo, E R Maher, and F Latif Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer Mol. Pathol., June 1, 2002; 55(3): 153 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, A. Zamparelli, F. U. Garcia, L. Claudio, G. Ammirati, A. Farina, A. Bovicelli, G. Russo, G. G. Giordano, D. E. McGinnis, et al. Expression of Cell-Cycle-regulated Proteins pRb2/p130, p107, p27kip1, p53, mdm-2, and Ki-67 (MIB-1) in Prostatic Gland Adenocarcinoma Clin. Cancer Res., June 1, 2002; 8(6): 1808 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chestukhin, L. Litovchick, K. Rudich, and J. A. DeCaprio Nucleocytoplasmic Shuttling of p130/RBL2: Novel Regulatory Mechanism Mol. Cell. Biol., January 15, 2002; 22(2): 453 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tong, D. Xie, J. O'Kelly, C. W. Miller, C. Muller-Tidow, and H. P. Koeffler Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer J. Biol. Chem., December 7, 2001; 276(50): 47709 - 47714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Gray, X. Guo, D. Kedra, B. T. Teh, X. Guo, and H.-Q. Min Correspondence re: P. P. Claudio et al., Mutations in the Retinoblastoma-related Gene RB2/p130 in Primary Nasopharyngeal Carcinoma. Cancer Res., 60: 8-12, 2000. Cancer Res., August 1, 2001; 61(15): 5950 - 5951. [Full Text] [PDF] |
||||
![]() |
M. G. Paggi and A. Giordano Who Is the Boss in the Retinoblastoma Family? The Point of View of Rb2/p130, the Little Brother Cancer Res., June 1, 2001; 61(12): 4651 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Burbee, E. Forgacs, S. Zochbauer-Muller, L. Shivakumar, K. Fong, B. Gao, D. Randle, M. Kondo, A. Virmani, S. Bader, et al. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression J Natl Cancer Inst, May 2, 2001; 93(9): 691 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Wade Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin Hum. Mol. Genet., April 1, 2001; 10(7): 693 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Nevins The Rb/E2F pathway and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, P. Stiegler, C. M. Howard, C. Bellan, C. Minimo, G. M. Tosi, J. Rak, A. Kovatich, Paola De Fazio, P. Micheli, et al. RB2/p130 Gene-enhanced Expression Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Vivo Cancer Res., January 1, 2001; 61(2): 462 - 468. [Abstract] [Full Text] |
||||
![]() |
J. Sage, G. J. Mulligan, L. D. Attardi, A. Miller, S. Chen, B. Williams, E. Theodorou, and T. Jacks Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization Genes & Dev., December 1, 2000; 14(23): 3037 - 3050. [Abstract] [Full Text] |
||||
![]() |
C. M. Howard, P. P. Claudio, Antonio De Luca, P. Stiegler, F. P. Jori, N. M. Safdar, M. Caputi, K. Khalili, and A. Giordano Inducible pRb2/p130 Expression and Growth-suppressive Mechanisms: Evidence of a pRb2/p130, p27Kip1, and Cyclin E Negative Feedback Regulatory Loop Cancer Res., May 1, 2000; 60(10): 2737 - 2744. [Abstract] [Full Text] |
||||
![]() |
P. P. Claudio, M. Caputi, and A. Giordano The RB2/p130 Gene: The Latest Weapon in the War against Lung Cancer? Clin. Cancer Res., March 1, 2000; 6(3): 754 - 764. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |